The Christmas festival is near and the medical agencies in the US are fearing the further rise in the Covid 19 cases. As more people will be traveling to their hometowns, it will lead to more selling of antigen-based self-testing kits in the United States.
Testing Kits And Antigen Based Testing Kits Shortage Rise
These testing kits are easily available at the local pharmacy shops and can be bought without doctors’ prescriptions so its demand is increasing as when people develop milder symptoms of the Covid 19, they tend to use these self-testing kits for self-satisfaction.
Also as the US Centers for Disease Control and Prevention has stated previously that tracking the positivity record of these testing kits is very difficult due to their wide availability without restrictions.
After the detection of the new Omicron variant in a fully vaccinated person in California, the concern over the rising cases has been giving sleepless nights to the health care experts. Previously, the variant covered nearly 1% of COVID cases, but this figure has now risen to 3% and 15 percent in some of the States in the US.
According to medical researchers, the Delta variant remains dominant in the United States, accounting for approximately 99 percent of all COVID 19 cases, including both versions.
According to the Centers for Disease Control and Prevention, there have been 50,181,003 COVID cases and more than 800,000 deaths since the early days of the virus. The total number of cases is expected to rise soon, and a new wave is expected by mid-January as the cases are increasing with an average rate of more than 30 percent.
Cough, fatigue, congestion, and a runny nose are the most common symptoms of the Omicron variant as stated by South African scientists, and the early symptoms are very milder as compared to the delta variant. These symptoms have been reported in patients who are currently infected with Omicron. The Omicron has a higher transmission rate, but it causes fewer deaths and has a lower severity in patients.
Health experts are concerned about a new wave that may arrive in the United States due to an increase in cases on a daily basis and it will be more contagious, which will be a challenge not only for hospitals but also for testing agencies.
Officials in the Biden administration have informed COVID-19 test manufacturers that due to the Omicron coronavirus variant, demand for tests could skyrocket in the coming months.
The supply of test kits may be in short supply during the community transfer when demand for the testing will be as high as 3 to 5 million tests per day.
The implications of the Omicron variant are still being assessed by scientists. Early evidence suggests it may cause less severe illness than the other variants, but “a lot of people” will still get infected, according to the Centers for Disease Control and Prevention Director Rochelle Walensky’s statement on Tuesday.